Benefits of SGLT2 Inhibitors Beyond Glycemic Control – A Focus on Metabolic, Cardiovascular and Renal Outcomes

Publisher: Bentham Science Publishers

E-ISSN: 1875-6417|14|6|509-517

ISSN: 1573-3998

Source: Current Diabetes Reviews, Vol.14, Iss.6, 2018-12, pp. : 509-517

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract